| editorial | Q871232 |
| scholarly article | Q13442814 |
| P2093 | author name string | D R Senger | |
| L Van De Water | |||
| P2860 | cites work | Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation | Q22004269 |
| Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins | Q24311459 | ||
| In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin | Q33180622 | ||
| Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells | Q34047111 | ||
| The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing | Q34582371 | ||
| Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. | Q35782323 | ||
| Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing | Q36231924 | ||
| Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis | Q36363657 | ||
| Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal | Q36558878 | ||
| Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner | Q36760948 | ||
| Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability | Q36857442 | ||
| Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors | Q37370535 | ||
| Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells | Q41144930 | ||
| Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability | Q41308865 | ||
| Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration | Q41711674 | ||
| Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. | Q42527570 | ||
| Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines | Q42803718 | ||
| Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation | Q42826789 | ||
| Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. | Q45052632 | ||
| Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels | Q46436248 | ||
| Post-transcriptional regulation of vascular endothelial growth factor by hypoxia | Q48066359 | ||
| Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia | Q48072985 | ||
| Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme | Q49168241 | ||
| Regulation of extravascular coagulation by microvascular permeability. | Q53902122 | ||
| Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. | Q55480542 | ||
| Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells | Q71893658 | ||
| Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells | Q72191064 | ||
| Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing | Q72259824 | ||
| Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer | Q72410073 | ||
| Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions | Q72592656 | ||
| Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin | Q73081960 | ||
| Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast | Q73872730 | ||
| Tumor induction of VEGF promoter activity in stromal cells | Q77349243 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-3 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | VEGF expression by epithelial and stromal cell compartments: resolving a controversy | |
| P478 | volume | 157 |
| Q24311459 | Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins |
| Q58761759 | Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients |
| Q35634609 | Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib |
| Q34140326 | Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas |
| Q30779379 | In vivo optical imaging of expression of vascular endothelial growth factor following laser incision in skin |
| Q47655346 | Interleukin-17A negatively regulates lymphangiogenesis in T helper 17 cell-mediated inflammation |
| Q34559451 | Non-angiogenic functions of VEGF in breast cancer |
| Q33573324 | VEGF targets the tumour cell |
| Q42794674 | Vascular endothelial growth factor, transforming growth factor-alpha, and estrogen receptors: possible cross-talks and interactions |
Search more.